Alison Bass
April 9, 2009
Earlier this week, Senator Charles Grassley announced a probe into the nation’s largest advocacy group for people with mental illness, the National Alliance for Mental Illness, asking the nonprofit group to disclose the funding it has received in recent years from the drug industry. The fact that NAMI is heavily dependent on drug company money is old news, but Grassley’s investigation, first reported in Bloomberg News, may shed a welcome spotlight on an lobbying organization that masquerades as grassroots.
In Side Effects, I reveal that drug company contributions have always been a substantial portion of NAMI’s revenues. I also tell the story of how Jim McNulty, president of NAMI from 2002 to 2004, failed to disclose the fact that he was being paid thousands of dollars from drug makers for promoting their products to NAMI members and others at various speaking engagements. In a particularly intriguing twist, McNulty laundered this drug company money through a state chapter of NAMI.
Read entire article: http://alison-bass.blogspot.com/2009/04/nami-exposed-drug-money-behind-this.html
News Feed
Related Posts
Tags: conflicts of interest, drug money, Eli Lilly, GlaxoSmithKline, NAMI, National Alliance on Mental Illness, Pfizer, Senator Charless Grassley
This entry was posted on Thursday, September 17th, 2009 at 2:28 pm and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
Donate
There are few severly depressed women who experience depression during pregancy.Normally this is a time of pure joy and happiness, so if there is depression in pregencancy cases that require electroconvuosive (ECT) therapy it is a rare situation.